BrightGene Bio-Medical Technology Co., Ltd.
688166 SHA







Weekly Report
BrightGene Bio-Medical Technology Co., Ltd. closed at 91.1800 (-1.67% WoW) . Data window ends Mon, 15 Sep 2025.
How to read this โ Price slope is downward, indicating persistent supply pressure. Elevated weekly volatility increases whipsaw risk. Volume and price are moving in the same direction โ a constructive confirmation. Distance to baseline is narrowing โ reverting closer to its fair-value track.
Down-slope argues for patience; rallies can fade sooner unless participation improves.
Gauge maps the trend signal to a 0โ100 scale.
How to read this โ Gauge is elevated but momentum is rolling over; topping risk is rising.
Stay alert: protect gains or seek confirmation before adding risk.
Price is above fair value; upside may be capped without catalysts.
Conclusion
Negative setup. โ โ โโโ confidence. Price window: -8. Trend: Uptrend at Risk; gauge 84. In combination, liquidity confirms the move.
- Liquidity confirms the price trend
- High-level but rolling over (topping risk)
- Momentum is weak/falling
- Price is not above key averages
- High return volatility raises whipsaw risk
Why: Price window -8.13% over 8w. Close is -21.73% below the prior-window high. Return volatility 5.54%. Volume trend falling. Liquidity convergence with price. Trend state uptrend at risk. High-regime (0.80โ1.00) downticks 3/7 (43.0%) โข Accumulating. Baseline deviation 1.65% (narrowing). Momentum neutral and falling. Valuation limited upside without catalysts.
Tip: Most metrics include a hover tooltip where they appear in the report.